日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

LOAd703诱导的肿瘤微环境基因工程联合阿特珠单抗治疗转移性恶性黑色素瘤:一项I/II期试验

Hamid, O; Ekström-Rydén, V; Mehmi, I; Wang, D; Patel, M; Alsaqal, S; Irenaeus, S; Nordström, C; Sandin, L C; Grauers Wiktorin, H; Lövgren, T; Eriksson, E; Leja-Jarblad, J; Loskog, A; Ullenhag, G J

Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients

对耐药性黑色素瘤患者进行髓系细胞重编程并恢复T细胞功能

Grauers Wiktorin, Hanna; Ekström-Rydén, Viktoria; Ek, Ida; Eriksson, Emma; Lövgren, Tanja; Bernedal Nordström, Clara; Sandin, Linda C; Patel, Meera R; Hamid, Omid; Ullenhag, Gustav; Loskog, Angelica

Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus

甲苯咪唑在自发性NZBxNZWF1系统性红斑狼疮动物模型中的疗效

Eloranta, M L; Nygren, P; Larsson, R; Loskog, A; Woodworth, N; Hultqvist, M; Svensson, Richard; Gravenfors, Ylva; Rönnblom, L; Fryknäs, Mårten

Safety of intratumoral immunostimulatory LOAd703 gene therapy combined with chemotherapy in patients with advanced cancer

肿瘤内免疫刺激性LOAd703基因疗法联合化疗治疗晚期癌症患者的安全性

Hahn, A; Irenaeus, S; Sandin, L C; Wenthe, J; Eriksson, E; Jarblad, J L; Schiza, A; Dahlstrand, H; Olsson-Strömberg, U; Krause, J; Sundin, A; Loskog, A; Ullenhag, G J

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

LOAd703(一种基于溶瘤病毒的免疫刺激基因疗法)联合化疗治疗不可切除或转移性胰腺癌(LOKON001):一项非随机、单中心、1/2期研究的第1组结果

Musher, Benjamin L; Rowinsky, Eric K; Smaglo, Brandon G; Abidi, Wasif; Othman, Mohamed; Patel, Kalpesh; Jawaid, Salmaan; Jing, James; Brisco, Amanda; Leen, Ann M; Wu, Mengfen; Sandin, Linda C; Wenthe, Jessica; Eriksson, Emma; Ullenhag, Gustav J; Grilley, Bambi; Leja-Jarblad, Justyna; Hilsenbeck, Susan G; Brenner, Malcolm K; Loskog, Angelica S I

CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling

CD40配体介导的CD40刺激可增强腺病毒介导的肿瘤免疫原性,包括“找到我”、“吃掉我”和“杀死我”信号传导。

Naseri, Sedigheh; Cordova, Mariela Mejia; Wenthe, Jessica; Lövgren, Tanja; Eriksson, Emma; Loskog, Angelica; Ullenhag, Gustav J

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

单细胞RNA分析揭示CAR T细胞的细胞内在功能与淋巴瘤患者II期研究的疗效相关

Tina Sarén # ,Mohanraj Ramachandran # ,Gustav Gammelgård ,Tanja Lövgren ,Claudio Mirabello ,Åsa K Björklund ,Kristina Wikström ,Jamileh Hashemi ,Eva Freyhult ,Håkan Ahlström ,Rose-Marie Amini ,Hans Hagberg ,Angelica Loskog ,Gunilla Enblad # ,Magnus Essand #

Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models

靶向 CD40、4-1BB 和 IL-2R 的免疫刺激基因疗法可激活树突状细胞 (DC),并在黑色素瘤模型中刺激抗原特异性 T 细胞和 NK 细胞反应。

Jessica Wenthe ,Emma Eriksson ,Ann-Charlotte Hellström ,Rafael Moreno ,Gustav Ullenhag ,Ramon Alemany ,Tanja Lövgren ,Angelica Loskog

Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition

利用靶向DC细胞和T细胞的基因疗法进行免疫启动,可使已治疗的和远处转移的B16肿瘤对检查点抑制剂更加敏感。

Wenthe, Jessica; Naseri, Sedigheh; Hellström, Ann-Charlotte; Moreno, Rafael; Ullenhag, Gustav; Alemany, Ramon; Lövgren, Tanja; Eriksson, Emma; Loskog, Angelica

Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

肾移植后供体来源泌尿系统肿瘤:一项回顾性非随机科学分析

Hellström, Vivan; Tufveson, Gunnar; Loskog, Angelica; Bengtsson, Mats; Enblad, Gunilla; Lorant, Tomas